Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders

The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,989 · see citing works

Diagnosis, management, and treatment of hepatitis C†

Strader, D. B., Wright, T. L., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,705 · see citing works

National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B

Sorrell, M. F., Belongia, E. A., Costa, J. C., Gareen, I. F., Grem, J. L., Inadomi, J. M., Kern, E. R., McHugh, J. A., Petersen, G. M., Rein, M. F., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00100 · Cited by 831 · see citing works

Management of hepatitis C

Alberti, A., & Benvegnù, L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00008-4 · Cited by 440 · see citing works

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

Schaefer, M., Schmidt, F., Folwaczny, C., Lorenz, R. L., Martin, G., Schindlbeck, N. E., Heldwein, W., Soyka, M., Grunze, H., Koenig, A., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50031 · Cited by 321 · see citing works

Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C

Schaefer, M., Schwaiger, M., Garkisch, A. S., Pich, M. G. L., Hinzpeter, A., Uebelhack, R., Heinz, A., van Bömmel, F., & Berg, T. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.01.020 · Cited by 175 · see citing works

A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance

Mauss, S., Berger, F., Goelz, J., Jacob, B., & Schmutz, G. (2004) · Hepatology · doi:10.1002/hep.20279 · Cited by 161 · see citing works

Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin

Schaefer, M., Hinzpeter, A., Mohmand, A., Janssen, G., Pich, M. G. L., Schwaiger, M., Sarkar, R., Friebe, A., Heinz, A., Kluschke, M., et al. (2007) · Hepatology · doi:10.1002/hep.21791 · Cited by 141 · see citing works

AASLD PRACTICE GUIDELINES:diagnosis,management,and treatment of hepatitis C:an update

Shaobin, Y. (2009) · Chinese Journal of Gastroenterology and Hepatology · Cited by 129 · see citing works

Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?

Schaefer, M., Heinz, A., & Backmund, M. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00821.x · Cited by 107 · see citing works

The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone

Sylvestre, D. L., Litwin, A. H., Clements, B. J., & Gourevitch, M. N. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.06.002 · Cited by 104 · see citing works

Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection

Grebely, J., Genoway, K. A., Khara, M., Duncan, F., Viljoen, M., Elliott, D., Raffa, J. D., DeVlaming, S., & Conway, B. (2007) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2007.01.009 · Cited by 99 · see citing works

Co-occurring Hepatitis C, Substance Use, and Psychiatric Illness: Treatment Issues and Developing Integrated Models of Care

Sylvestre, D. L. (2004) · Journal of Heredity · doi:10.1093/jurban/jth153 · Cited by 99 · see citing works

Response To Treatment of Hepatitis C in Individuals With A Recent History of Intravenous Drug Abuse

Thiel, D. H. V., Anantharaju, A., & Creech, S. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07702.x · Cited by 98 · see citing works

Integrating Services for Injection Drug Users Infected with Hepatitis C Virus with Methadone Maintenance Treatment: Challenges and Opportunities

Litwin, A. H., Soloway, I. J., & Gourevitch, M. N. (2005) · Clinical Infectious Diseases · doi:10.1086/427450 · Cited by 81 · see citing works

Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes

Robaeys, G., Vlierberghe, H. V., Mathe, C., Ranst, M. A. V., & Bruckers, L. M. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200602000-00008 · Cited by 80 · see citing works

Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users

Grebely, J., Raffa, J. D., Meagher, C., Duncan, F., Genoway, K. A., Khara, M., McLean, M., Mead, A., Viljoen, M., DeVlaming, S., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05032.x · Cited by 75 · see citing works

Response to treatment of hepatitis C in individuals with a recent history of intravenous drug abuse

Thiel, D. V. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00708-1 · Cited by 68 · see citing works

Blood-Borne Infections and Persons With Mental Illness: The Five-Site Health and Risk Study of Blood-Borne Infections Among Persons With Severe Mental Illness

Rosenberg, S. D., Swanson, J. W., Wolford, G. L., Osher, F. C., Swartz, M. S., Essock, S. M., Butterfield, M. I., Marsh, B. J., & the Five-Site Health and Risk Study Research Committee (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.6.827 · Cited by 58 · see citing works

Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants

Jeffrey, G. P., MacQuillan, G. C., Chua, F., Galhenage, S., Bull, J., Young, E., Hulse, G. K., & O’Neil, G. (2006) · Hepatology · doi:10.1002/hep.21470 · Cited by 57 · see citing works

Treatment for Hepatitis C Virus Infection among Current Injection Drug Users in Australia

Matthews, G. V., Kronborg, I. J., & Dore, G. J. (2005) · Clinical Infectious Diseases · doi:10.1086/427448 · Cited by 55 · see citing works

Cannabis use improves retention and virological outcomes in patients treated for hepatitis C

Sylvestre, D. L., Clements, B. J., & Malibu, Y. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000216934.22114.51 · Cited by 54 · see citing works

Hepatitis C Treatment Eligibility and Outcomes Among Patients With Psychiatric Illness

Rifai, M. A., Moles, J. K., & Short, D. D. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.4.570 · Cited by 51 · see citing works

Hepatitis C Treatment of Opioid Dependants Receiving Maintenance Treatment: Results of a Norwegian Pilot Study

Krook, A. L., Stokka, D., Heger, B., & Nygaard, E. (2007) · European Addiction Research · doi:10.1159/000104884 · Cited by 48 · see citing works

Hepatitis C in Schizophrenia: Screening Experience in a Community-Dwelling Clozapine Cohort

Freudenreich, O., Gandhi, R. T., Walsh, J. P., Henderson, D. C., & GOFF, D. C. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.5.405 · Cited by 45 · see citing works

Delivering Care to Injection Drug Users Coinfected with HIV and Hepatitis C Virus

Taylor, L. E. (2005) · Clinical Infectious Diseases · doi:10.1086/427453 · Cited by 44 · see citing works

Hepatitis C and HIV Infections: Implications for Clinical Care in Injection Drug Users

Sullivan, L. E., & Fiellin, D. A. (2004) · American Journal on Addictions · doi:10.1080/10550490490265271 · Cited by 43 · see citing works

Hepatitis C Treatment for People With Severe Mental Illness

Mistler, L. A., Brunette, M. F., Marsh, B. J., Vidaver, R. M., Luckoor, R., & Rosenberg, S. D. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.2.93 · Cited by 39 · see citing works

Referral for chronic hepatitis C treatment from a drug dependency treatment setting

Hallinan, R., Byrne, A., Agho, K., & Dore, G. J. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.09.018 · Cited by 39 · see citing works

Effectiveness of a multi‐disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes

Guadagnino, V., Trotta, M. P., Montesano, F., Babudieri, S., Caroleo, B., Armignacco, O., Carioti, J., Maio, G. D., Monarca, R., Antinori, A., et al. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01698.x · Cited by 36 · see citing works

Hepatitis C Screening and Treatment Outcomes in Patients With Substance Use/Dependence Disorders

Rifai, M. A., Moles, J. K., Lehmann, L. P., & Linden, B. J. V. D. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.2.112 · Cited by 36 · see citing works

Peginterferon Alfa-2a Does Not Alter the Pharmacokinetics of Methadone in Patients with Chronic Hepatitis C Undergoing Methadone Maintenance Therapy*

Sulkowski, M., Wright, T. L., Rossi, S., Arora, S., Lamb, M. W., Wang, K., Gries, J., & Yalamanchili, S. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.09.008 · Cited by 34 · see citing works

Psychiatric management of the hepatitis C patient

Rifai, M. A., Indest, D. W., Loftis, J. M., & Hauser, P. (2006) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-006-0007-6 · Cited by 29 · see citing works

Does depression symptomatology affect medication compliance during the first weeks of anti-HCV therapy in intravenous drug users?

Guadagnino, V., Trotta, M. P., Carioti, J., Caroleo, B., & Antinori, A. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.10.008 · Cited by 27 · see citing works

Interferon alpha-2a Plus Ribavirin 1,000/1,200 mg versus Interferon alpha-2a Plus Ribavirin 600 mg for Chronic Hepatitis C Infection in Patients on Opiate Maintenance Treatment: An Open-Label Randomized Multicenter Trial

Huber, M., Weber, R. K., Oppliger, R., Vernazza, P., Schmid, P., Sch�nbucher, P., Bertisch, B., Meili, D., & Renner, E. L. (2005) · Infection · doi:10.1007/s15010-005-4043-2 · Cited by 24 · see citing works

Approaching Treatment for Hepatitis C Virus Infection in Substance Users

Sylvestre, D. L. (2005) · Clinical Infectious Diseases · doi:10.1086/429501 · Cited by 24 · see citing works

Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: A prospective, nonrandomized, crossover study in patients coinfected with hepatitis c and hiv receiving methadone maintenance treatment

Berk, S. I., Litwin, A. H., Arnsten, J. H., Du, E. Y., Soloway, I. J., & Gourevitch, M. N. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.01.009 · Cited by 23 · see citing works

The Effect of Multiple Doses of Peginterferon alfa‐2b on the Steady‐State Pharmacokinetics of Methadone in Patients With Chronic Hepatitis C Undergoing Methadone Maintenance Therapy

Gupta, S. K., Sellers, E. M., Somoza, E. C., Angles, L., Kolz, K., & Cutler, D. L. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007299760 · Cited by 22 · see citing works

Hepatitis C in patients with psychiatric disease and substance abuse: Screening strategies and comanagement models of care

Loftis, J. M., & Hauser, P. (2003) · Current Hepatology Reports · doi:10.1007/s11901-003-0002-5 · Cited by 15 · see citing works

Delivering Therapy for Hepatitis C Virus Infection to Incarcerated HIV-Seropositive Patients

McGovern, B., Fiore, J. P., Wurcel, A. G., Taglienti, P., Bradley, M., Galvin, S., Libone, G., Ramsey, J., Molinaro-Gudas, V., Drewniak, S. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/429497 · Cited by 15 · see citing works

False Reduction in Serum Methadone Concentrations by BD Vacutainer® Serum Separator Tubes (SST™)

Berk, S. I., Litwin, A. H., Du, Y. E., Cruikshank, G., Gourevitch, M. N., & Arnsten, J. H. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.072132 · Cited by 10 · see citing works

New paradigms in the management of hepatitis C virus co-infections

Sherman, K. E. (2007) · Nature Clinical Practice Gastroenterology &#38 Hepatology · doi:10.1038/ncpgasthep0692 · Cited by 9 · see citing works

Recent IV-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: An open-label pilot study

Witthoeft, T. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i4.579 · Cited by 7 · see citing works

Treatment of Hepatitis C Infected Substance Abusers within a Community-Based, Outpatient Methadone Maintenance Program

Freedman, K. I., McLaughlin, P., & Strong, P. (2005) · The American Journal of Gastroenterology · doi:10.14309/00000434-200509001-00267 · Cited by 1 · see citing works

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488 · see citing works

Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues

Bonner, J. E., Barritt, A. S., Fried, M. W., & Evon, D. M. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2141-4 · Cited by 32 · see citing works

The Use of Psychoeducation for a Patient with Hepatitis C and Psychiatric Illness in Preparation for Antiviral Therapy: A Case Report and Discussion

Hong, B. A., North, C. S., Pollio, D. E., Abbacchi, A. M., Debold, C., Adewuyi, S. A., & Lisker‐Melman, M. (2011) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-011-9227-6 · Cited by 15 · see citing works

Tangible Resources for Preparing Patients for Antiviral Therapy for Chronic Hepatitis C

Bonner, J. E., Barritt, A. S., Fried, M. W., & Evon, D. M. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2142-3 · Cited by 14 · see citing works

Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review

Hepworth, J., Bain, T., & van Driel, M. (2013) · International Journal for Equity in Health · doi:10.1186/1475-9276-12-92 · Cited by 10 · see citing works

Letter

Lin, H., Yang, L., & Chiu, W.-T. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.3.327 · Cited by 6 · see citing works

Innovative Approaches to Engaging Homeless and Marginally Housed Patients in Care: a Case Study of Hepatitis C

Conti, J., Dryden, E. M., Fincke, B. G., Dunlap, S. W., & McInnes, D. K. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07708-w · Cited by 5 · see citing works

Hepatitis C

Tillmann, H. L., & McHutchison, J. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00031-0 · Cited by 3 · see citing works

Perspectives on the management of chronic hepatitis B and C

Dusheiko, G. M., & Jacobs, M. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.16 · Cited by 2 · see citing works

Letter

Pathak, P., West, D., & Martin, B. C. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.3.325 · Cited by 2 · see citing works

Hepatitis C treatment and injecting drug users in Perth, Western Australia: Knowledge of personal status and eligibility criteria for treatment

CARRUTHERS, S. J., & Ryan, C. (2010) · Journal of Substance Use · doi:10.3109/14659891.2010.513757 · Cited by 1 · see citing works

Traitement intégré de l’hépatite C auprès des personnes avec des troubles concomitants de santé mentale et de dépendance : promouvoir le changement en milieu urbain

Chayer, M.-C., Vieux, M.-G., Bruneau, J., & Jutras‐Aswad, D. (2012) · Santé mentale au Québec · doi:10.7202/1008591ar · Cited by 1 · see citing works

Letter

Rifai, M. A. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.3.325a · Cited by 1 · see citing works

World Psychiatryis indexed in PubMed, Current Contents/Clinical Medicine, Current Contents/Social and Behavioral Sciences, Science Citation Index, and EMBASE Âñåìèðíàÿ Ïñèõèàòðè÷åñêàÿ Àññîöèàöèÿ (ÂÏÀ)

Maj, M., Ïðåçèäåíò, È., Tasman, A., & Herrman, H. (2011)

Letter

Kakisi, O. K., Karageorgopoulos, D. E., & Falagas, M. E. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.3.326

Letter

Brown, J., Singer, E., & Ireys, H. T. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.3.328

Case Report of 3 Patients with Severe Mental Illness and Chronic Hepatitis C Virus Infection Treated with Interferon-Alpha

Mistler, L. A., Brunette, M. F., Rosenberg, S. D., Vidaver, R. M., Luckoor, R., & Iber, M. C. (2006) · The International Journal of Psychiatry in Medicine · doi:10.2190/1336-74m1-1718-73g1 · Cited by 6 · see citing works

Management of Mental Health Problems Prior to and During Treatment of Hepatitis C Virus Infection in Patients With Drug Addiction

Schaefer, M., Sarkar, R., & Díez, C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit266 · Cited by 42 · see citing works

Díez-Quevedo C. Management of mental health problems prior to and during treatment of hepatitis C virus infection in patients with drug addiction. Clin Infecrt Dis

Schaefer, M., Sarkar, R., & Díez, C. (2016)

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

Schaefer, M., Schmidt, F., Folwaczny, C., Lorenz, R. L., Martin, G., Schindlbeck, N. E., Heldwein, W., Soyka, M., Grunze, H., Koenig, A., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50031 · Cited by 321 · see citing works

VIRAL HEPATITIS Adherence and Mental Side Effects During Hepatitis C Treatment With Interferon Alfa and Ribavirin in Psychiatric Risk Groups

Schaefer, M., Schmidt, F., Folwaczny, C., Lorenz, R., Martin, G., Schindlbeck, N. E., Heldwein, W., Soyka, M., Heinz Grunze, A., Koenig, A., et al. (2013)